SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-323087
Filing Date
2019-12-26
Accepted
2019-12-26 08:21:42
Documents
20
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d837333d8k.htm   iXBRL 8-K 50583
2 EX-4.1 d837333dex41.htm EX-4.1 945023
3 EX-10.1 d837333dex101.htm EX-10.1 94659
4 EX-10.2 d837333dex102.htm EX-10.2 205201
5 EX-10.3 d837333dex103.htm EX-10.3 117617
6 EX-99.1 d837333dex991.htm EX-99.1 13497
7 EX-99.2 d837333dex992.htm EX-99.2 9909
11 GRAPHIC g837333g1223135134161.jpg GRAPHIC 3533
12 GRAPHIC g837333g1226093118670.jpg GRAPHIC 4340
  Complete submission text file 0001193125-19-323087.txt   1886392

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA acor-20191220.xsd EX-101.SCH 3065
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20191220_lab.xml EX-101.LAB 17375
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20191220_pre.xml EX-101.PRE 10950
22 EXTRACTED XBRL INSTANCE DOCUMENT d837333d8k_htm.xml XML 3277
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 191308391
SIC: 2836 Biological Products, (No Diagnostic Substances)